CME Group, Inc. (CME) Tops Q2 EPS Views; Revs Strong
Tweet
Share
E-mailGet Alerts CME Hot Sheet
Price: $269.80 +0.97%
Financial Fact:
Amortization of purchased intangibles: 24M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Amortization of purchased intangibles: 24M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
CME Group, Inc. (NASDAQ: CME) reported Q2 EPS of $4.38, $0.21 better than the analyst estimate of $4.17. Revenue for the quarter came in at $838 million versus the consensus estimate of $821.33 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CME Group plans NHL index-based futures launch for September 28
- Reading (RDI) Tops Q2 EPS by 4c
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
